Clinical trial Recruiting at 1 site Observational Ages 18 and up

CIDI 5.0 validation against SCID-5 for lifetime mental disorders in Hong Kong adults

Official title: Validity of the World Health Organization CIDI 5.0 for Assessing Lifetime Prevalence of Mental Disorders: A Clinical Reappraisal Study Using the SCID-5

Run by The University of Hong Kong · NCT07604753 · Data updated 2026-11-12

This study tests whether the CIDI 5.0 interview can reliably identify lifetime mental disorders in adults in Hong Kong by comparing it with the SCID-5 diagnostic interview.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment300 (estimated)
SponsorThe University of Hong Kong
Academic / other
Locations1 site (Hong Kong)
StatusRecruiting
StartedMay 14, 2025
Main results expectedJanuary 2028
Study endsJanuary 2028
Registry record updatedMay 22, 2026
Trial IDNCT07604753 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults 18+ who reside in Hong Kong, can read Chinese or English, and do not have cognitive or linguistic barriers.

Probably not a fit

Participants unable to complete interviews in Chinese or English or with cognitive difficulties may receive limited diagnostic insight from the interview.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study evaluates the validity of the CIDI 5.0, a structured diagnostic interview, against the SCID-5 gold standard for lifetime mental disorders (MDD, GAD, PTSD) in a population-based sample in Hong Kong. Randomly sampled adults 18+ from local housing are assessed in Chinese or English. The study leverages updated DSM-5 criteria and prior Qatar data to examine specificity and sensitivity of CIDI 5.0 in real-world settings. Outcomes focus on concordance with clinical diagnoses and potential applicability for large-scale epidemiological research. The design emphasizes population-based validity rather than clinical treatment effects.

Why it matters

Potential benefit: If successful, CIDI 5.0 could be a reliable, cost-effective tool for large-scale mental health surveys and epidemiology in Hong Kong.

How similar studies have gone: Prior international studies showed varying concordance; this study builds on Qatar findings and aims to establish validity in a new population.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* All household members aged 18 years old and over are randomly sampled from the Census and Statistics Department List of Quarters
* Live in the address sampled from the Census and Statistics Department List of Quarters
* Reside in Hong Kong for at least six months in the past year
* Able to read and communicate in Chinese or English
* Without linguistic or cognitive difficulties

Exclusion Criteria:

* Domestic workers

Where it's running

  • The University of Hong Kong
    Hong Kong, Hong Kong
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.